Healthy Lifestyle in Adults With Attention Deficit Hyperactivity Disorder
NCT ID: NCT00879320
Last Updated: 2013-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
253 participants
OBSERVATIONAL
2009-02-28
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Adults with ADHD
No interventions assigned to this group
2
Healthy adults without ADHD
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Signed written informed consent to participate in the study.
2. Age: 18 - 60 (inclusive).
3. Current diagnosis of DSM-IV ADHD by structured interview. Late age of onset acceptable for participation provided ADHD symptoms meet full criteria currently.
Control Subjects
1. Signed written informed consent to participate in the study.
2. Age: 18 - 60 (inclusive).
3. Subjects must have \<3 symptoms in each domain (Inattention and Hyperactive/Impulsive) and \<5 total symptoms in both domains on the DSM-IVADHD module of the structured interview.
Exclusion Criteria
2. Mental impairment as evidenced by a Full Scale I.Q. less than 80.
3. Major sensorimotor handicaps such as deafness or blindness.
4. Subject currently taking antipsychotic medication or mood stabilizers.
5. Inadequate command of the English language.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shire
INDUSTRY
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas J. Spencer, MD
Associate Chief, Clinical and Research Program, Pediatric Psychopharmacology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Spencer, MD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Cambridge, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-P-002056
Identifier Type: -
Identifier Source: org_study_id